Close Menu

In the PNAS Early Edition this week, a public-private research collaboration among academicians and investigators at array technology vendors reports its development of a 6.9 million-feature oligonucleotide "human transcriptome array for high-throughput clinical studies." When compared to that of RNA-seq, the team says, this transcriptome array "allows comprehensive examination of gene expression and genome-wide identification of alternative splicing as well as detection of coding S

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The US Food and Drug Administration is to announce stricter standards for emergency authorizations of SARS-CoV-2 vaccines, reports the Washington Post.

The Associated Press reports Johnson & Johnson is starting a late-stage clinical trial of its candidate SARS-CoV-2 vaccine.

Bloomberg reports the budget of Operation Warp Speed is actually $18 billion, higher than the number typically cited.

In Genome Research this week: genomic analysis reveals role of super-spreaders in SARS-CoV-2, epigenetic drivers of cancer, and more.